To check effect of vasa ghrita orally in treatment of senile immature cataract

To study the efficacy of Vasaghrita abhyantar sevan in Senile Immature Cataract

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/042158

Enrollment

Registered

2022-04-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H250- Age-related incipient cataract

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients of incipient stage cataract of age group 40 to 80 years irrespective of gender and occupation is included.Patients having classical signs and symptoms of incipient stage cataract is included.Patients having visual acuity 6 by 36 or more will be selected for this study

Exclusion criteria

Exclusion criteria: patients having age group below 40 and above 80 year are excluded patients having vision less than 6 by 36 will be excluded Patients having systemic diseases except diabetes and hypertension will be excluded Patients who are having glaucoma corneal ulcer dacryocystitis or any type of ocular surface diseases or retinal or any diabetic and hypertensive pathology will be excluded

Design outcomes

Primary

Measure	Time frame
To delay the development or progression of opacity in lens and its capsule and maintenance of the visual acuity along with decrease in symptoms like visual glareTimepoint: 60 days study with 4 follow up (0, 15th, 30th, 45th, 60th day)	—

Secondary

Measure	Time frame
There may be delay in progress of senile immature cataractTimepoint: 60 days study with 4 follow up (0, 15th, 30th, 45th, 60th day)	—

Countries

India

Contacts

Public ContactDr Pranita Pratap Deshmukh

Bharati Vidyapeeth (Deemed to be University)College of Ayurved and Hospital,Pune

drsantoshmulik@gmail.com9823491389

Outcome results